Status
Conditions
Treatments
About
Hypermobility Spectrum Disorder and hypermobile Ehlers-Danlos Syndrome (HSD/hEDS) is under-recognized and poorly understood and its management is therefore not clear.
The goal of this study is to better understand pain and its impact on function in the daily activities of adolescents with Hypermobility Spectrum Disorder and/or hypermobile Ehlers-Danlos Syndrome.
This study will explore the presence of the pain sensitivity status after physical exercise as well as movement behaviour in adolescents with HSD/hEDS compared to a healthy control group.
Full description
All participants will be asked not to undertake physical exercise at least 48 hours before the measurements, and to refrain from consuming caffeine, alcohol or nicotine. For ethical reasons, the patients are allowed to take non-opioid pain medicine as described in the first step of the World Health Organization analgesic ladder (COX-inhibitors and paracetamol), however the patients will be asked to abstain from these medications during the 24 hours period before the measurements.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion criteria for the HSD/hEDS group:
Exclusion criteria for the HSD/hEDS group:
Inclusion criteria for the control group:
Exclusion criteria for the control group:
100 participants in 2 patient groups
Loading...
Central trial contact
Elke S Hjalmarsson, PhD-student; Mari Lundberg, Professor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal